|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ARONEX PHARMACEUTICALS INC, 10-Q, 2000-08-14 |
Next: ARONEX PHARMACEUTICALS INC, 10-Q, EX-27.1, 2000-08-14 |
<PAGE> 1
ARONEX PHARMACEUTICALS, INC. AND SUBSIDIARIES
STATEMENT REGARDING COMPUTATION OF PER SHARE EARNINGS
The following reflects the information used in calculating the number of
shares in the computation of net loss per share for each of the periods set
forth in the Statements of Operations.
<TABLE>
<CAPTION>
INCOME
AVERAGE (LOSS)
DAYS SHARES INCOME PER
SHARES OUTSTANDING SHARES X DAYS OUTSTANDING (LOSS) SHARE
<S> <C> <C> <C> <C> <C> <C>
SIX MONTHS ENDED JUNE 30, 1999:
16,379,309 3 49,137,927
16,415,664 50 820,783,200
22,415,664 14 313,819,296
22,463,211 21 471,727,431
22,474,987 1 22,474,987
22,494,671 1 22,494,671
22,495,050 64 1.439,683,200
22,496,505 26 584,909,130
22,555,435 1 22,555,435
181 3,747,585,277 /181 20,704,891 (1,906,000) (0.09)
SIX MONTHS ENDED JUNE 30, 2000:
22,853,782 21 479,929,422
22,873,782 3 68,621,346
22,876,765 4 91,507,060
22,877,930 12 274,535,160
22,879,230 23 526,222,290
22,888,646 6 137,331,876
22,905,144 14 320,672,016
22,922,078 54 1,237,792,212
25,854,652 44 1,137,604,688
25,890,127 1 25,890,127
182 4,300,106,197 /182 23,626,957 (7,918,000) (0.34)
QUARTER ENDED JUNE 30, 1999:
(BASIC) 22,495,050 64 1,439,683,200
22,496,505 26 584,909,130
22,555,435 1 22,555,435
92 2,047,147,765 /91 22,496,129 1,269,000 0.06
QUARTER ENDED JUNE 30, 1999: 22,652,230 19 430,392,370
(DILUTED) 22,652,380 14 317,133,320
22,652,592 8 181,220,736
22,661,974 10 226,619,740
23,236,687 14 325,313,618
23,237,687 25 580,942,175
23,297,072 1 23,297,072
91 2,084,919,031 /91 22,911,198 1,269,000 0.06
QUARTER ENDED JUNE 30, 2000:
22,922,078 47 1,077,337,666
25,854,652 44 1,137,604,688
25,890,127 1 25,890,127
92 2,240,832,481 /92 24,356,875 (4,466,000) (0.18)
</TABLE>
|
|